Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-09-19

Clinical Trial Update: Assess the Influence of Cenobamate on the PK of Cytochrome P450 (CYP) Probe Drugs As a Means of Predicting Drug-drug Interactions [Phase 1]

View source ↗

Summary

Phase 1 study assessing how cenobamate influences the pharmacokinetics of CYP450 probe drugs to predict potential drug-drug interactions; study completed in hea…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Cenobamate (cenobamate)

Snippet

Sponsor: SK Life Science, Inc. | Conditions: Healthy | Phase 1 | Status: COMPLETED